Bracco, a global leader in diagnostic imaging, has announced plans to build its first manufacturing facility in the United States with a $230 million investment. The new sterile manufacturing plant will be located in Sanford, North Carolina, and is projected to create approximately 200 jobs in the region.
This facility will produce injectable contrast media, essential components used in diagnostic imaging procedures such as CT and MRI scans. The investment marks Bracco’s expansion beyond its existing production sites in Europe, Asia, and Canada, signaling a significant development in strengthening the U.S. supply chain for critical medical imaging materials.
North Carolina officials have welcomed the project, endorsing a 12-year Job Development Investment Grant to support Bracco’s establishment of this advanced manufacturing site. While the company has yet to disclose specific details on the construction timeline and operational commencement, the new plant is expected to enhance domestic manufacturing capacity and reduce reliance on overseas sources.
The move aligns with broader industry efforts to localize production of key healthcare technologies and improve supply chain resilience amid ongoing global uncertainties. Bracco’s investment reflects confidence in the U.S. manufacturing workforce and regional infrastructure that can support advanced pharmaceutical and medical device production.
Bracco’s Sanford facility represents a meaningful addition to the American healthcare manufacturing landscape, offering prospects for job creation and supporting the availability of critical diagnostic tools for the nation’s medical system.


